EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Study to Compare the Safety and Efficacy of Solifenacin, Tamsulosin and Tadalafil in Relieving Double-J Stent Related Symptoms

Appiya Ramamoorthy Balaji, Pritam Pritish Patnaik, Javangula Venkata Surya Prakash, Sattanathan Vetrichandar, Krishnan Vembu Arasi, Arun Kumar Paranjothi, Vetrivel Natarajan

Open Journal of Urology · 2020 · 10 (03) · 42-51

DOI: 10.4236/oju.2020.103006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Open Journal of Urology, 2020. Verfasst von Appiya Ramamoorthy Balaji und 6 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective: To evaluate and compare the safety and efficacy of Solifenacin, Tamsulosin, and Tadalafil in treating ureteral stent related symptoms (SRS) in patients with indwelling Double-J ureteral stents. Materials and Methods: A prospective randomized controlled study was conducted on 146 consecutive patients in the department of urology, Government Stanley Medical College & Hospital, Chennai, Tamilnadu, India between Sept 2017-March 2019, with SRS after taking informed consent and confirming DJ Stent position by X-ray KUB post-operatively. Patients were randomized into 4 groups: Group A (Placebo), Group B (Solifenacin 5 mg), and Group B (Tamsulosin 0.4 mg) and group D (Tadalafil 5 mg) at end of 1st week till the removal of DJ stent at end of 3 weeks. All patients were assessed for bothersome lower urinary tract symptoms (LUTS) using the validated Ureteral Stent Symptom Questionnaire (USSQ) at 1st week and 3 weeks after the starting of medications. Appropriate statistical analysis as carried out and the level of significance was set at P α-blockers in relieving urinary symptoms and is more efficacious in relieving sexual symptoms and body pain.

Zitieren

APA

Balaji, A. R., Patnaik, P. P., Prakash, J. V. S., Vetrichandar, S., Arasi, K. V., Paranjothi, A. K., & Natarajan, V. (2020). A Study to Compare the Safety and Efficacy of Solifenacin, Tamsulosin and Tadalafil in Relieving Double-J Stent Related Symptoms. Open Journal of Urology, 10(03), 42-51. https://doi.org/10.4236/oju.2020.103006

Vancouver

Balaji AR, Patnaik PP, Prakash JVS, Vetrichandar S, Arasi KV, Paranjothi AK, et al. A Study to Compare the Safety and Efficacy of Solifenacin, Tamsulosin and Tadalafil in Relieving Double-J Stent Related Symptoms. Open Journal of Urology. 2020;10(03):42-51. doi:10.4236/oju.2020.103006

BibTeX
@article{Balaji2020,
  author = {Balaji, Appiya Ramamoorthy and Patnaik, Pritam Pritish and Prakash, Javangula Venkata Surya and Vetrichandar, Sattanathan and Arasi, Krishnan Vembu and Paranjothi, Arun Kumar and Natarajan, Vetrivel},
  title = {A Study to Compare the Safety and Efficacy of Solifenacin, Tamsulosin and Tadalafil in Relieving Double-J Stent Related Symptoms},
  journal = {Open Journal of Urology},
  year = {2020},
  volume = {10},
  number = {03},
  pages = {42--51},
  doi = {10.4236/oju.2020.103006}
}
Kostenlos starten →